| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |